1Institute of Virology, Chinese Academy of Preventive Medicine, Beijing 100052.
Researchers produced a recombinant antigen for a hepatitis E virus vaccine. The expressed protein specifically reacted with patient antibodies, suggesting its potential utility in vaccine development against hepatitis E virus infection.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: